Problem statement: Answer the MCQ question.
Query: Which drug exhibits a 17.892\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a) Cc1nnc(NC(=O)CCn2c(=O)oc3ccccc32)s1
b) CCCCn1c(N)c(N(CC(C)C)C(=O)CCCc2cccs2)c(=O)[nH]c1=O
Answer: a. Cc1nnc(NC(=O)CCn2c(=O)oc3ccccc32)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nnc(NC(=O)CCn2c(=O)oc3ccccc32)s1
Cc1nnc(NC(=O)CCn2c(=O)oc3ccccc32)s1
N-(5-methyl-1,3,4-thiadiazol-2-yl)-3-(2-oxo-1,3-benzoxazol-3-yl)propanamide